McKesson (MCK) Tops Q3 EPS by 18c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Jefferies says this healthcare stock is one of its top picks
February 6, 2026 6:30 PM ESTJefferies highlighted one of its top healthcare picks in a note to clients this week, citing strong fundamentals and execution that have driven margin and earnings growth.
Analyst Brian Tanquilut said the bullish stance on McKesson (NYSE: MCK) is largely driven by what we view as very compelling secular trends and growth outlook in the drug... More



